DG DISPATCH - AACAP: Paroxetine Ineffective For Adolescent Unipolar Depression
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




DG DISPATCH - AACAP: Paroxetine Ineffective For Adolescent Unipolar Depression

By Lara Pullen
Special to DG news

CHICAGO, IL -- October 22, 1999 -- While depression in adults has been well-studied, adolescent depression and the optimal pharmacotherapy for this age group is not as well understood. A recent study addresses this data gap with evidence that paroxetine, a selective serotonin reuptake inhibitor (SSRI), is not an effective treatment for adolescent unipolar depression.

Dr. Robert P. Milin, of Royal Ottawa Hospital, in Ottawa, ON, presented the results of an international, placebo-controlled, clinical trial yesterday (Oct. 21) at the 46th annual meeting of the American Academy of Child and Adolescent Psychiatry (AACAP). The objective of the study was to assess the efficacy and safety of paroxetine in the treatment of adolescents with unipolar major depression.

The studied consisted of 286 patients aged 13 to 18 years who were randomized to receive paroxetine (20-40 mg daily) or placebo for 12 weeks. No statistically significant differences were detected between the two groups. The data did suggest, however, that adolescents over the age of 16 might respond positively to paroxetine treatment.

While the study results are generally negative, Dr. Milin believes that it is important that even negative findings be reported. These results are especially critical during the investigative stages of pharmacological trials as they add to the understanding and optimization of drug therapies.

"We all know that medications work for certain kids… The question is how do you go about prescribing them," Dr. Milin explained.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities